242 related articles for article (PubMed ID: 21479203)
1. The alternative splice variant of protein tyrosine kinase 6 negatively regulates growth and enhances PTK6-mediated inhibition of β-catenin.
Brauer PM; Zheng Y; Evans MD; Dominguez-Brauer C; Peehl DM; Tyner AL
PLoS One; 2011 Mar; 6(3):e14789. PubMed ID: 21479203
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic retention of protein tyrosine kinase 6 promotes growth of prostate tumor cells.
Brauer PM; Zheng Y; Wang L; Tyner AL
Cell Cycle; 2010 Oct; 9(20):4190-9. PubMed ID: 20953141
[TBL] [Abstract][Full Text] [Related]
3. Identification of beta-catenin as a target of the intracellular tyrosine kinase PTK6.
Palka-Hamblin HL; Gierut JJ; Bie W; Brauer PM; Zheng Y; Asara JM; Tyner AL
J Cell Sci; 2010 Jan; 123(Pt 2):236-45. PubMed ID: 20026641
[TBL] [Abstract][Full Text] [Related]
4. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
[TBL] [Abstract][Full Text] [Related]
5. PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer.
Zheng Y; Wang Z; Bie W; Brauer PM; Perez White BE; Li J; Nogueira V; Raychaudhuri P; Hay N; Tonetti DA; Macias V; Kajdacsy-Balla A; Tyner AL
Cancer Res; 2013 Sep; 73(17):5426-37. PubMed ID: 23856248
[TBL] [Abstract][Full Text] [Related]
6. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.
Zheng Y; Gierut J; Wang Z; Miao J; Asara JM; Tyner AL
Oncogene; 2013 Sep; 32(36):4304-12. PubMed ID: 23027128
[TBL] [Abstract][Full Text] [Related]
7. Context-specific protein tyrosine kinase 6 (PTK6) signalling in prostate cancer.
Zheng Y; Tyner AL
Eur J Clin Invest; 2013 Apr; 43(4):397-404. PubMed ID: 23398121
[TBL] [Abstract][Full Text] [Related]
8. Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer.
Mathur PS; Gierut JJ; Guzman G; Xie H; Xicola RM; Llor X; Chastkofsky MI; Perekatt AO; Tyner AL
Mol Cancer Res; 2016 Jun; 14(6):563-73. PubMed ID: 26983689
[TBL] [Abstract][Full Text] [Related]
9. Protein tyrosine kinase 6 negatively regulates growth and promotes enterocyte differentiation in the small intestine.
Haegebarth A; Bie W; Yang R; Crawford SE; Vasioukhin V; Fuchs E; Tyner AL
Mol Cell Biol; 2006 Jul; 26(13):4949-57. PubMed ID: 16782882
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the mouse protein tyrosine kinase 6 gene prevents STAT3 activation and confers resistance to azoxymethane.
Gierut J; Zheng Y; Bie W; Carroll RE; Ball-Kell S; Haegebarth A; Tyner AL
Gastroenterology; 2011 Oct; 141(4):1371-80, 1380.e1-2. PubMed ID: 21741923
[TBL] [Abstract][Full Text] [Related]
11. NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma.
Kim YJ; Yoon SY; Kim JT; Song EY; Lee HG; Son HJ; Kim SY; Cho D; Choi I; Kim JH; Kim JW
Carcinogenesis; 2009 Apr; 30(4):598-605. PubMed ID: 19237607
[TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine kinase 6 directly phosphorylates AKT and promotes AKT activation in response to epidermal growth factor.
Zheng Y; Peng M; Wang Z; Asara JM; Tyner AL
Mol Cell Biol; 2010 Sep; 30(17):4280-92. PubMed ID: 20606012
[TBL] [Abstract][Full Text] [Related]
13. beta-catenin regulates multiple steps of RNA metabolism as revealed by the RNA aptamer in colon cancer cells.
Lee HK; Kwak HY; Hur J; Kim IA; Yang JS; Park MW; Yu J; Jeong S
Cancer Res; 2007 Oct; 67(19):9315-21. PubMed ID: 17909039
[TBL] [Abstract][Full Text] [Related]
14. Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells.
Guo L; Zhong D; Lau S; Liu X; Dong XY; Sun X; Yang VW; Vertino PM; Moreno CS; Varma V; Dong JT; Zhou W
Mol Cancer Res; 2008 Sep; 6(9):1421-30. PubMed ID: 18819930
[TBL] [Abstract][Full Text] [Related]
15. Exon-intron structure of the human PTK6 gene demonstrates that PTK6 constitutes a distinct family of non-receptor tyrosine kinase.
Lee H; Kim M; Lee KH; Kang KN; Lee ST
Mol Cells; 1998 Aug; 8(4):401-7. PubMed ID: 9749526
[TBL] [Abstract][Full Text] [Related]
16. PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors.
Peng M; Emmadi R; Wang Z; Wiley EL; Gann PH; Khan SA; Banerji N; McDonald W; Asztalos S; Pham TN; Tonetti DA; Tyner AL
Oncotarget; 2014 Aug; 5(15):6038-48. PubMed ID: 25153721
[TBL] [Abstract][Full Text] [Related]
17. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
[TBL] [Abstract][Full Text] [Related]
18. Axin downregulates TCF-4 transcription via beta-catenin, but not p53, and inhibits the proliferation and invasion of lung cancer cells.
Yang LH; Xu HT; Han Y; Li QC; Liu Y; Zhao Y; Yang ZQ; Dong QZ; Miao Y; Dai SD; Wang EH
Mol Cancer; 2010 Feb; 9():25. PubMed ID: 20122174
[TBL] [Abstract][Full Text] [Related]
19. Positive inter-regulation between beta-catenin/T cell factor-4 signaling and endothelin-1 signaling potentiates proliferation and survival of prostate cancer cells.
Sun P; Xiong H; Kim TH; Ren B; Zhang Z
Mol Pharmacol; 2006 Feb; 69(2):520-31. PubMed ID: 16291872
[TBL] [Abstract][Full Text] [Related]
20. Protein-tyrosine kinase 6 promotes peripheral adhesion complex formation and cell migration by phosphorylating p130 CRK-associated substrate.
Zheng Y; Asara JM; Tyner AL
J Biol Chem; 2012 Jan; 287(1):148-158. PubMed ID: 22084245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]